It has previously been shown that antibodies to double-stranded (ds) native DNA have a high degree of specificity for systemic lupus erythematosus (SLE) (Pincus et al., 1969; Hughes, 1971 ). In addition, serial studies of these antibodies during the course of the disease have shown that in most patients a good degree of correlation exists between antibody levels and evidence of disease remission or relapse (Lightfoot et al., 1973; Davis et al., 1977a) . Several problems with radioimmunoassays for the detection of DNA antibodies remain to be resolved. The purity of DNA used in each assay has to be clearly defined, as sera from patients with systemic lupus erythematosus and many other diseases also contain antibodies to other polynucleotides, especially single-stranded (ss) DNA. Singlestranded DNA present as an impurity in test-DNA will cause spuriously high levels of antibody binding to be recorded (Winfield and Davis, 1974). The validity of DNA assay results, therefore, can be interpreted only with the knowledge of the specific nature of the DNA.
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A further problem in quantitation of antibody to native DNA is standardisation, not only between laboratories but also in the same laboratory from year to year. This problem is compounded by the number of different assay systems and different The development of a standardised commercially available assay for quantitation of DNA antibodies, suitable for routine clinical application, would potentially be of value. We have had the opportunity to test one such commercially available assay provided by Amersham/Searlel and have demonstrated (Davis et al., 1977b ) that a good degree of correlation occurs between the presence of antibodies to double-stranded DNA as detected by this method, and antibodies to double-stranded DNA as detected by the Millipore filter assay with the 3H-DNA procedure now used routinely in our laboratory.
The aim of the present study was to evaluate the use of this standardised assay in routine clinical practice after careful assessment of the purity of the radiolabelled DNA. Analysis on a caesium chloride gradient shows a single peak of radioactive DNA and no radioactivity in the RNA fraction. Selective absorption chromotography on hydroxy apatite shows < 1% single stranded DNA (Holian et al.,1975; Holian, personal communication, 1976) .
Methods
This degree of purity of radioactive antigen has been confirmed in our own laboratory. The DNA was not found to contain significant contamination with ss DNA by the following criteria.
ETHIDIUM BROMIDE TECHNIQUE (Morgan and Pulleybank, 1974) Ethidium intercalates into the DNA duplex with, at low ionic strengths, a binding constant of around 107 M-1 and with a 50-fold increase in the fluorescence of ethidium. The high binding constant and the intrinsic sensitivity of fluorescence allows DNA to be very sensitively assayed, 0X1 ug being quantitated to + 1 %. In order to differentiate between native and denatured DNA, the much lower stability of the short intramolecular base-pairing that occurs in denatured DNA relative to the fully duplex native DNA is exploited. Heat denatured DNA can be made completely single-stranded by raising the pH to 11 8, while under the same conditions native DNA remains intact. Thus at pH 8, owing to the short intramolecular base-pairing of denatured DNA, it shows a fluorescence about 50% that of native DNA at pH 8. However, at pH 11 -8 no fluorescence is observed for denatured DNA at all owing to destabilisation of intramolecular basepaired regions. The procedure is performed according to the detailed instructions, and a curve of counts (1251 counts) is plotted against the anti-DNA antibody concentration in units per ml using the standards included. Anti-DNA antibody concentration in the same units per ml in the unknown serum can then be extracted from the standard curve as drawn. In most cases, where anti-DNA antibody activity is greater than the maximum standard serum provided, these antibody activities can be calculated by repeating the test using dilutions of the unknown serum.
Using this technique we have tested 78 sera from 54 patients with SLE fulfilling the ARA criteria (Cohen et al., 1971) , 50 sera from patients with classical rheumatoid arthritis (RA) fulfilling the ARA criteria (Ropes et al., 1959) , 33 sera from patients with progressive systemic sclerosis (PSS), and 57 sera from patients with definite ankylosing spondylitis (AS) fulfilling the New York criteria (Bennett and Burch, 1967) . Fifty sera from normal subjects have been evaluated for the presence of DNA antibodies and used as controls.
Results
Results of DNA antibody concentration in the serum tested are expressed in the Table. Using this kit, levels of DNA binding greater than 50 units were seen only in the sera from patients with SLE. No sera from the other disease groups tested had more than 50 units. Five sera from patients with SLE had 25-50 units of DNA binding, but levels in the same range were seen also in one serum from a patient with PSS and in six sera from patients with RA. All sera from patients with AS and the majority of sera from patients with RA and PSS bound less than 25 units of DNA. Some patients with SLE whose disease was in remission also bound levels less than 25 units.
These results suggested that the upper limit of normal of 25 units of DNA bound per ml, as expressed by the manufacturers, may be too low for the most effective differentiation between patients with SLE and other connective tissue diseases, particularly rheumatoid arthritis.
Discussion
Our results show that the Amersham/Searle assay kit is a convenient, reliable, and reproducible, method for detecting antibodies to double-stranded DNA. In particular, the kit has clinical value and does appear to differentiate between those sera containing significant amounts of n-DNA antibodies and those which do not, as has previously been reported (Holian et al., 1975) . The few false positive results could be eliminated if the upper limit of normal were designated as 50 units per ml.
The inclusion of known standards is an important factor as it allows for interlaboratory standardisation. In the past, however, most workers in this field have included known standards of their own when routinely testing for double-stranded DNA antibodies in their own laboratory using their own specific technique and DNA. This approach has led to day-to-day standardisation within one laboratory although it has not improved interlaboratory reference. While the inclusion of standards with the assay kit will overcome this to some extent it is perhaps unfortunate that another expression of results has had to be introduced (ie, units DNA bound/ml).
The main advantage of this assay system is the nature of the DNA used as test antigen. Recent reports have clearly shown that the differing antigens used in different centres do not necessarily react similarly in given test conditions. In particular, variations in molecular weight and contamination with ss DNA can significantly alter results (Aarden et al., 1975; Picazo and Tan, 1975) .
This problem has previously been emphasised in other studies using differing assay systems and differing DNA (Winfield and Davis, 1974) . Evaluation of the nature of the test antigen used is there-fore critical as impure antigen will lead to falsely high results which will reduce the sensitivity and specificity of the assay. Our assessment of the purity of the 125I HeLa cell DNA used in this kit, with the low levels of ss DNA, suggests a high degree of specificity of the antibody being measured. Although this DNA has a high MW (107) relative to other DNAs, variations in MW due to age and batch with differing chain lengths will again be overcome by the inclusion of the known standards.
It is our opinion that this standardised assay and others like it will be of clinical value in measuring anti-DNA antibodies in the routine service laboratory and will improve the reliability with which DNA antibody results can be interpreted. 
